Neostigmine
reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery
Indications
- reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery
Adult dosing
- nmba reversal: dose: 0.03; unit: mg/kg; route: IV; interval: 0.03 mg/kg to 0.07 mg/kg; weightBased: true; labelExcerpt: For reversal of NMBAs with shorter half-lives, when first twitch response is substantially greater than 10% of baseline, or when a second twitch is present: 0.03 mg/kg by intravenous route. (2.2) - For reversal of NMBAs with longer half-lives or when first twitch response is close to 10% of baseline: 0 .07 mg/kg by intravenous route .
Pediatric dosing
- nmba reversal: dose: 0.03; unit: mg/kg; route: IV; interval: 0.03 mg/kg to 0.07 mg/kg; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: The dose of neostigmine methylsulfate injection required to reverse neuromuscular blockade in children varies between 0.03 mg to 0.07 mg/kg, the same dose range shown to be effective in adults, and should be selected using the same criteria as used for adult patients.
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- hypersensitivity to neostigmine
- peritonitis
- mechanical obstruction of intestinal or urinary tract
Clinical pearls
- Must be administered with an anticholinergic (atropine or glycopyrrolate) to prevent bradycardia.
- Use peripheral nerve stimulation (TOF) to guide dosing and titration.
- Administer by IV injection slowly over at least 1 minute.
- Monitor for adequacy of reversal to ensure patient can ventilate and maintain airway.
Source and review
- DailyMed label (neostigmine methylsulfate), Set ID 673140f7-273e-4543-98b5-6b12c59f540b, effective 2026-10-09. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties